Results 161 to 170 of about 2,747 (207)

Managing high-grade prostatic intraepithelial neoplasia (HGPIN) and atypical glands on prostate biopsy

Nature Reviews Urology, 2017
Prostate biopsy is the gold standard for diagnosing prostate cancer and reliable pathological assessment is essential for guiding management. Research efforts over the past few years have aimed to establish a more universal approach to management according to pathological grading; however, high-grade prostatic intraepithelial neoplasia (HGPIN) and ...
Jeffrey J Tosoian, Ridwan Alam, Mark W Ball   +2 more
exaly   +3 more sources

Prognostic Significance of High-Grade Prostatic Intraepithelial Neoplasia (HGPIN): Risk of Prostatic Cancer on Repeat Biopsies

Urology, 2008
To verify prognostic significance of high-grade prostatic intraepithelial neoplasia (HGPIN) in 65 patients who underwent repeat biopsies with a mean follow-up of 36 months.In June 2007, after a retrospective revision of the biopsy reports that were performed between January 2002 and December 2006 because of prostate specific antigen (PSA) values ...
Ezio Venturino
exaly   +3 more sources

High-grade prostatic intraepithelial neoplasia (HGPIN)

2023
exaly   +2 more sources

Overexpression of ERG in HGPIN predicts prostate cancer

Nature Reviews Urology, 2013
exaly   +2 more sources

Apolipoprotein‐D: A novel cellular marker for HGPIN and prostate cancer

The Prostate, 2003
AbstractBACKGROUNDHigh grade prostatic intraepithelial neoplasia (HGPIN) is a putative pre‐malignant lesion of the prostate. While apolipoprotein‐D (Apo‐D), an androgen‐regulated hydrophobic transporter protein, is expressed in prostate tumors, its expression in HGPIN is unknown.METHODSImmunoreactivity for Apo‐D and another androgen‐regulated protein ...
Neufing, Petra, Ricciardelli, Carmela, Horsfall, David J, Tilley, Wayne Desmond, Hall, R E, Vivekanandan, Suchindra, Stahl, Jurgen, Stapleton, Alan Murray, Scardino, P T   +8 more
openaire   +3 more sources

Management of High-Grade Prostatic Intraepithelial Neoplasia (HGPIN)

2012
The diagnosis of isolated high-grade prostatic intraepithelial neoplasia (HGPIN) is based on findings of atypical nuclei in cells lining architecturally benign glands. This premalignant entity is associated with increased risk of coexistent cancer or delayed progression to carcinoma.
Krishna Ramaswamy, Herbert Lepor, Samir S. Taneja   +2 more
openaire   +1 more source

[A proteomic study of the serum proteins in BPH and HGPIN patients].

Zhonghua nan ke xue = National journal of andrology, 2008
To evaluate two-dimensional gel electrophoresis (2DGE) and mass spectrometry in the studies of the serum proteins expressed in patients with BPH and those with high-grade prostatic intraepithelial neoplasm (HGPIN).We extracted serum proteins from BPH and HGPIN patients by 2DGE and cut the differentially expressed interesting protein spots from the gel.
Xiao-Jian, Gu, Qing-Yi, Zhu, Lin, Yuan, Jian, Su, Wei-Zhou, Huang, Yang, Zhang, Ze-Yu, Sun   +6 more
openaire   +1 more source

Role of endorectal MR and MR-spectroscopy in patients with HGPIN and elevated PSA. Our experience.

2012
Purpose Methods and Materials Results Conclusion References Personal ...
openaire   +1 more source

Effects of Soy Protein Isolate Consumption on Prostate Cancer Biomarkers in Men With HGPIN, ASAP, and Low-Grade Prostate Cancer

Nutrition and Cancer, 2007
Fifty-eight men at high risk of prostate cancer or with low-grade prostate cancer were randomly assigned to consume 1 of 3 protein isolates containing 40 g protein: 1) soy protein (SPI+, 107 mg isoflavones/d); 2) alcohol-washed soy protein (SPI-,
Jill M, Hamilton-Reeves, Salome A, Rebello, Will, Thomas, Mindy S, Kurzer, Joel W, Slaton   +4 more
openaire   +2 more sources

The predictive value of HGPIN and ASAP for the subsequent diagnosis of prostate cancer in the Reduction by Dutasteride of Cancer Events (REDUCE) study.

Journal of Clinical Oncology, 2010
4561 Background: REDUCE was a 4-year, randomized placebo (pbo) controlled study of prostate cancer (PCa) risk reduction with once daily dutasteride 0.5 mg (dut). This analysis examines the effect of dut on initial detection of high-grade prostatic intraepithelial neoplasia (HGPIN) and/or atypical small acinar proliferation (ASAP) and the incidence of ...
D. G. Bostwick, D. J. Tindall, C. A. Pettaway, T. L. Tammela, C. Teloken, T. H. Wilson, R. S. Castro   +6 more
openaire   +1 more source